Selected research
Industry Research
DNA-Encoded Library Screening Services Industry Research Report 2026
Market perspective
The global DNA-Encoded Library Screening Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the DNA-Encoded Library Screening Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the DNA-Encoded Library Screening Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the DNA-Encoded Library Screening Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of DNA-Encoded Library Screening Services include Pharmaron, Vipergen, Novalix, DyNAbind, MedChemExpress, BioDuro-Sundia, Charles River Laboratories, Chemspace and X-Chem, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global DNA-Encoded Library Screening Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to DNA-Encoded Library Screening Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DNA-Encoded Library Screening Services Market by Company
Pharmaron
Vipergen
Novalix
DyNAbind
MedChemExpress
BioDuro-Sundia
Charles River Laboratories
Chemspace
X-Chem
HitGen
WuXi AppTec
DNA-Encoded Library Screening Services Segment by Type
Provider-Owned Library Screening
Client-Provided Library Screening
Custom-Built Library Screening
Consortium or Shared-Access Library Screening
DNA-Encoded Library Screening Services Segment by Application
Oncology Drug Discovery
Immunology and Inflammation Drug Discovery
Neurology Drug Discovery
Infectious Disease Drug Discovery
Metabolic and Cardiovascular Drug Discovery
Other Therapeutic Discovery
DNA-Encoded Library Screening Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA-Encoded Library Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA-Encoded Library Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA-Encoded Library Screening Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of DNA-Encoded Library Screening Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Provider-Owned Library Screening
- Client-Provided Library Screening
- Custom-Built Library Screening
- Consortium or Shared-Access Library Screening
Applications
- Oncology Drug Discovery
- Immunology and Inflammation Drug Discovery
- Neurology Drug Discovery
- Infectious Disease Drug Discovery
- Metabolic and Cardiovascular Drug Discovery
- Other Therapeutic Discovery
Companies covered
- Pharmaron
- Vipergen
- Novalix
- DyNAbind
- MedChemExpress
- BioDuro-Sundia
- Charles River Laboratories
- Chemspace
- X-Chem
- HitGen
- WuXi AppTec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 DNA-Encoded Library Screening Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Provider-Owned Library Screening
- 2.2.3 Client-Provided Library Screening
- 2.2.4 Custom-Built Library Screening
- 2.2.5 Consortium or Shared-Access Library Screening
- 2.3 DNA-Encoded Library Screening Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Oncology Drug Discovery
- 2.3.3 Immunology and Inflammation Drug Discovery
- 2.3.4 Neurology Drug Discovery
- 2.3.5 Infectious Disease Drug Discovery
- 2.3.6 Metabolic and Cardiovascular Drug Discovery
- 2.3.7 Other Therapeutic Discovery
- 2.4 Assumptions and Limitations
3 DNA-Encoded Library Screening Services Breakdown Data by Type
- 3.1 Global DNA-Encoded Library Screening Services Historic Market Size by Type (2021-2026)
- 3.2 Global DNA-Encoded Library Screening Services Forecasted Market Size by Type (2027-2032)
4 DNA-Encoded Library Screening Services Breakdown Data by Application
- 4.1 Global DNA-Encoded Library Screening Services Historic Market Size by Application (2021-2026)
- 4.2 Global DNA-Encoded Library Screening Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global DNA-Encoded Library Screening Services Market Perspective (2021-2032)
- 5.2 Global DNA-Encoded Library Screening Services Growth Trends by Region
- 5.2.1 Global DNA-Encoded Library Screening Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 DNA-Encoded Library Screening Services Historic Market Size by Region (2021-2026)
- 5.2.3 DNA-Encoded Library Screening Services Forecasted Market Size by Region (2027-2032)
- 5.3 DNA-Encoded Library Screening Services Market Dynamics
- 5.3.1 DNA-Encoded Library Screening Services Industry Trends
- 5.3.2 DNA-Encoded Library Screening Services Market Drivers
- 5.3.3 DNA-Encoded Library Screening Services Market Challenges
- 5.3.4 DNA-Encoded Library Screening Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top DNA-Encoded Library Screening Services Players by Revenue
- 6.1.1 Global Top DNA-Encoded Library Screening Services Players by Revenue (2021-2026)
- 6.1.2 Global DNA-Encoded Library Screening Services Revenue Market Share by Players (2021-2026)
- 6.2 Global DNA-Encoded Library Screening Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of DNA-Encoded Library Screening Services Head Office and Area Served
- 6.4 Global DNA-Encoded Library Screening Services Players, Product Type & Application
- 6.5 Global DNA-Encoded Library Screening Services Manufacturers Established Date
- 6.6 Global DNA-Encoded Library Screening Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America DNA-Encoded Library Screening Services Market Size (2021-2032)
- 7.2 North America DNA-Encoded Library Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America DNA-Encoded Library Screening Services Market Size by Country (2021-2026)
- 7.4 North America DNA-Encoded Library Screening Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe DNA-Encoded Library Screening Services Market Size (2021-2032)
- 8.2 Europe DNA-Encoded Library Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe DNA-Encoded Library Screening Services Market Size by Country (2021-2026)
- 8.4 Europe DNA-Encoded Library Screening Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific DNA-Encoded Library Screening Services Market Size (2021-2032)
- 9.2 Asia-Pacific DNA-Encoded Library Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific DNA-Encoded Library Screening Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific DNA-Encoded Library Screening Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America DNA-Encoded Library Screening Services Market Size (2021-2032)
- 10.2 South America DNA-Encoded Library Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America DNA-Encoded Library Screening Services Market Size by Country (2021-2026)
- 10.4 South America DNA-Encoded Library Screening Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa DNA-Encoded Library Screening Services Market Size (2021-2032)
- 11.2 Middle East & Africa DNA-Encoded Library Screening Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa DNA-Encoded Library Screening Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa DNA-Encoded Library Screening Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Pharmaron
- 12.1.1 Pharmaron Company Information
- 12.1.2 Pharmaron Business Overview
- 12.1.3 Pharmaron Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.1.4 Pharmaron DNA-Encoded Library Screening Services Product Portfolio
- 12.1.5 Pharmaron Recent Developments
- 12.2 Vipergen
- 12.2.1 Vipergen Company Information
- 12.2.2 Vipergen Business Overview
- 12.2.3 Vipergen Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.2.4 Vipergen DNA-Encoded Library Screening Services Product Portfolio
- 12.2.5 Vipergen Recent Developments
- 12.3 Novalix
- 12.3.1 Novalix Company Information
- 12.3.2 Novalix Business Overview
- 12.3.3 Novalix Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.3.4 Novalix DNA-Encoded Library Screening Services Product Portfolio
- 12.3.5 Novalix Recent Developments
- 12.4 DyNAbind
- 12.4.1 DyNAbind Company Information
- 12.4.2 DyNAbind Business Overview
- 12.4.3 DyNAbind Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.4.4 DyNAbind DNA-Encoded Library Screening Services Product Portfolio
- 12.4.5 DyNAbind Recent Developments
- 12.5 MedChemExpress
- 12.5.1 MedChemExpress Company Information
- 12.5.2 MedChemExpress Business Overview
- 12.5.3 MedChemExpress Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.5.4 MedChemExpress DNA-Encoded Library Screening Services Product Portfolio
- 12.5.5 MedChemExpress Recent Developments
- 12.6 BioDuro-Sundia
- 12.6.1 BioDuro-Sundia Company Information
- 12.6.2 BioDuro-Sundia Business Overview
- 12.6.3 BioDuro-Sundia Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.6.4 BioDuro-Sundia DNA-Encoded Library Screening Services Product Portfolio
- 12.6.5 BioDuro-Sundia Recent Developments
- 12.7 Charles River Laboratories
- 12.7.1 Charles River Laboratories Company Information
- 12.7.2 Charles River Laboratories Business Overview
- 12.7.3 Charles River Laboratories Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.7.4 Charles River Laboratories DNA-Encoded Library Screening Services Product Portfolio
- 12.7.5 Charles River Laboratories Recent Developments
- 12.8 Chemspace
- 12.8.1 Chemspace Company Information
- 12.8.2 Chemspace Business Overview
- 12.8.3 Chemspace Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.8.4 Chemspace DNA-Encoded Library Screening Services Product Portfolio
- 12.8.5 Chemspace Recent Developments
- 12.9 X-Chem
- 12.9.1 X-Chem Company Information
- 12.9.2 X-Chem Business Overview
- 12.9.3 X-Chem Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.9.4 X-Chem DNA-Encoded Library Screening Services Product Portfolio
- 12.9.5 X-Chem Recent Developments
- 12.10 HitGen
- 12.10.1 HitGen Company Information
- 12.10.2 HitGen Business Overview
- 12.10.3 HitGen Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.10.4 HitGen DNA-Encoded Library Screening Services Product Portfolio
- 12.10.5 HitGen Recent Developments
- 12.11 WuXi AppTec
- 12.11.1 WuXi AppTec Company Information
- 12.11.2 WuXi AppTec Business Overview
- 12.11.3 WuXi AppTec Revenue in DNA-Encoded Library Screening Services Business (2021-2026)
- 12.11.4 WuXi AppTec DNA-Encoded Library Screening Services Product Portfolio
- 12.11.5 WuXi AppTec Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst